|
Volumn 23, Issue 4, 2013, Pages 1051-1055
|
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase
|
Author keywords
Anti platelet therapy; Hit to lead; Tyrosine receptor kinase
|
Indexed keywords
2,4 DIAMINOPYRIMIDINE 5 CARBOXAMIDE;
2,4 DIAMINOPYRIMIDINE DERIVATIVE;
AMIDE;
PROTEIN TYROSINE KINASE INHIBITOR;
TYROSINE KINASE RECEPTOR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG IDENTIFICATION;
DRUG METABOLISM;
ENZYME INHIBITION;
IC 50;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
RAT;
REACTION OPTIMIZATION;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION;
AMIDES;
ANIMALS;
HUMANS;
MICE;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUBSTRATE SPECIFICITY;
|
EID: 84872892894
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.12.028 Document Type: Article |
Times cited : (11)
|
References (8)
|